产品详情
所在位置: 首页> 产品目录> 一抗>
查看大图

  • 产品名称：anti-Apoptosis,CaspaseActivationInhibitor(AVEN)(AA78-106),(N-Term)antibody

  • 产品型号：
  • 产品厂商：半导体
  • 产品文档：
你添加了1件商品 查看购物车
简单介绍：
anti-Apoptosis,CaspaseActivationInhibitor(AVEN)(AA78-106),(N-Term)antibody
详情介绍：
Immunogen This AVEN antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 78-106 amino acids from the N-terminal region of human AVEN.
Clone RB41905
Purification This antibody is purified through a protein A column, followed by peptide affinity purification. Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)
Alternative Name AVEN (AVEN Antibody Abstract)
Background AVEN protects against apoptosis mediated by Apaf-1.

Synonyms: AVEN, Cell death regulator Aven
NCBI Accession NP_065104
UniProt Q9NQS1
Research Area Cancer, Apoptosis/Necrosis
Application Notes WB: 1:1000
Restrictions For Research Use only
Format Liquid
Concentration 0.5 mg/mL
Buffer Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
Preservative Sodium azide
Precaution of Use WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Supplier Images
Western Blotting (WB) image for anti-Apoptosis, Caspase Activation Inhibitor (AVEN) (AA 78-106), (N-Term) antibody (ABIN1881095) AVEN Antibody (N-term) (ABIN1881095) western blot analysis in A2058 cell line lysates...
Product cited in: Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." in: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, 2010 (PubMed).

Ruaño, Thompson, Kane, Pullinger, Windemuth, Seip, Kocherla, Holford, Wu: "Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol?" in: Pharmacogenomics, Vol. 11, Issue 7, pp. 959-71, 2010 (PubMed).

Sugarbaker, Richards, Gordon, Dong, De Rienzo, Maulik, Glickman, Chirieac, Hartman, Taillon, Du, Bouffard, Kingsmore, Miller, Farmer, Jensen, Gullans, Bueno: "Transcriptome sequencing of malignant pleural mesothelioma tumors." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 105, Issue 9, pp. 3521-6, 2008 (PubMed).